Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11
- PMID: 7726169
- PMCID: PMC1801462
Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostoses loci on chromosomes 8 and 11
Abstract
Hereditary multiple exostoses (EXT; MIM 133700) is an autosomal dominant condition characterized by growth of multiple benign cartilage-capped tumors. EXT greatly increases the relative risk to develop chondrosarcoma, although most chondrosarcomas are sporadic. This observation suggests that, like the genes responsible for retinoblastoma and other dominantly inherited cancer susceptibility disorders, the genes that cause EXT may have tumor-suppressor function and may play a role in the pathogenesis of the related sporadic tumors. To investigate this hypothesis, we evaluated chondrosarcomas for loss of constitutional heterozygosity (LOH) at polymorphic loci linked to three recently identified genomic regions containing genes involved in EXT. LOH for markers linked to EXT1 on chromosome 8 was detected in a chondrosarcoma that arose in a man with EXT. Four of 17 sporadic tumors showed LOH for markers linked to EXT1, and 7 showed LOH for markers linked to EXT2 on chromosome 11. In all, LOH was observed for markers linked to EXT1 or EXT2 in 44% of the 18 tumors, whereas heterozygosity was retained for markers on 19p linked to EXT3. These findings support the hypothesis that genes on 8q and the pericentromeric region of 11 have tumor-suppressor function and play a role in the development of chondrosarcomas.
Similar articles
-
Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.Am J Hum Genet. 1995 May;56(5):1125-31. Am J Hum Genet. 1995. PMID: 7726168 Free PMC article.
-
Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies.Am J Hum Genet. 1997 Jan;60(1):80-6. Am J Hum Genet. 1997. PMID: 8981950 Free PMC article.
-
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.Am J Hum Genet. 1998 Feb;62(2):346-54. doi: 10.1086/301726. Am J Hum Genet. 1998. PMID: 9463333 Free PMC article.
-
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.Hum Mutat. 2000;15(3):220-7. doi: 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K. Hum Mutat. 2000. PMID: 10679937 Review.
-
[From gene to disease; hereditary multiple exostoses].Ned Tijdschr Geneeskd. 2002 Jan 26;146(4):162-4. Ned Tijdschr Geneeskd. 2002. PMID: 11845565 Review. Dutch.
Cited by
-
EXTL2, a member of the EXT family of tumor suppressors, controls glycosaminoglycan biosynthesis in a xylose kinase-dependent manner.J Biol Chem. 2013 Mar 29;288(13):9321-33. doi: 10.1074/jbc.M112.416909. Epub 2013 Feb 10. J Biol Chem. 2013. PMID: 23395820 Free PMC article.
-
The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis.J Exp Med. 2000 Jan 3;191(1):9-22. doi: 10.1084/jem.191.1.9. J Exp Med. 2000. PMID: 10620601 Free PMC article.
-
No evidence of microsatellite instability in bone tumours.Br J Cancer. 1996 Aug;74(3):453-5. doi: 10.1038/bjc.1996.380. Br J Cancer. 1996. PMID: 8695363 Free PMC article.
-
No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.Am J Pathol. 2010 Oct;177(4):1946-57. doi: 10.2353/ajpath.2010.100296. Epub 2010 Sep 2. Am J Pathol. 2010. PMID: 20813973 Free PMC article.
-
Heparan sulfate proteoglycans and cancer.Br J Cancer. 2001 Oct 19;85(8):1094-8. doi: 10.1054/bjoc.2001.2054. Br J Cancer. 2001. PMID: 11710818 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous